Pan-cancer Proteogenomics Expands the Landscape of Therapeutic Targets

CDK7 Summary

Tier:
T3; Target of drugs classified as investigational or experimental
Investigational drugs:
Name Database Indication
BS-181GtoPdb-
Cdk/Crk inhibitorGtoPdb-
samuraciclibGtoPdb-
THZ1GtoPdb-

*BRCA and GBM do not have normal samples.